Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 01/12/23
Due: 01/12/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) | NCT06246786 | Virginia G. Kaklamani | user2@example.com | None | 2024-07-01 | 2027-07-31 | 2028-07-31 | - | - | 2025-07-14 |
| Eribulin and Lenvatinib in Advanced Solid Tumors | NCT02640508 | Virginia G. Kaklamani | user2@example.com | None | 2016-05-31 | 2023-01-12 | 2024-01-12 | - | - | 2025-07-14 |